HBK Sorce Advisory’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,725
Closed -$209K 604
2024
Q4
$209K Sell
3,725
-1
-0% -$62 0.01% 533
2024
Q3
$254K Buy
+3,726
New +$210K 0.01% 484
2023
Q3
Sell
-2,975
Closed -$279K 572
2023
Q2
$279K Buy
2,975
+3
+0.1% +$234 0.01% 456
2023
Q1
$202K Sell
2,972
-4,866
-62% -$313K 0.01% 544
2022
Q4
$388K Buy
+7,838
New +$320K 0.01% 475
2022
Q1
Sell
-2,816
Closed -$219K 575
2021
Q4
$219K Sell
2,816
-83
-3% -$7.33K 0.01% 536
2021
Q3
$277K Sell
2,899
-221
-7% -$23.3K 0.02% 466
2021
Q2
$388K Buy
+3,120
New +$372K 0.02% 381
2020
Q4
Sell
-4,358
Closed -$444K 502
2020
Q3
$444K Buy
4,358
+291
+7% +$25.1K 0.03% 279
2020
Q2
$354K Sell
4,067
-100
-2% -$7.99K 0.03% 305
2020
Q1
$242K Buy
+4,167
New +$338K 0.02% 328

Other funds holding EXAS

HBK Sorce Advisory's EXAS Position: Q1 2025 in Review

HBK Sorce Advisory sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 3,725 shares — an estimated $209K sold.

HBK Sorce Advisory first reported a position in EXAS in Q1 2020 and held it in 11 quarters. The position peaked at $444K in Q3 2020. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • HBK Sorce Advisory reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • HBK Sorce Advisory sold 3,725 Exact Sciences shares in Q1 2025, an estimated $209K.
  • HBK Sorce Advisory first reported a position in Exact Sciences in Q1 2020 and held it in 11 quarters.
  • HBK Sorce Advisory's Exact Sciences position peaked at $444K in Q3 2020.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on HBK Sorce Advisory's 13F filing for Q1 2025, filed 23 Apr 2025.